Examples of using Refacto in English and their translations into Portuguese
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
FVIII activity in patient plasma were measured using the chromogenic substrate assay, ReFacto AF was shown to be bioequivalent to ReFacto. .
These packs will include information on the differences between ReFacto and ReFacto AF, how to use ReFacto AF safely,
in the European Union(EU), for patients receiving ReFacto AF and for laboratories that will monitor patients receiving ReFacto AF.
Frequency of Occurrence per Patient with ReFacto or ReFacto AF System organ class.
What is the risk associated with ReFacto AF?
The name of the medicine was also changed from ReFacto to ReFacto AF.
ReFacto AF 1000 IU powder for solution for injection.
The table lists adverse reactions reported in the clinical trials with ReFacto or ReFacto AF.
ReFacto AF 1000 IU powder and solvent for solution for injection.
The reconstituted ReFacto AF product should be injected intravenously over several minutes.
This indicates no time-dependent changes in the pharmacokinetic properties of ReFacto AF.
ReFacto AF has functional characteristics comparable to those of endogenous factor VIII.
Pharmacokinetic parameter estimates for ReFacto in previously treated patients with haemophilia A.
In PUPs, pharmacokinetic parameters of ReFacto were evaluated using the chromogenic assay.
ReFacto AF is given by injection into a vein lasting several minutes.
ReFacto AF has no influence on the ability to drive
dosing and monitoring of ReFacto AF.
Your doctor will decide the dose of ReFacto AF you will receive.
ReFacto AF contains the active substance moroctocog alfa,
ReFacto AF 250 IU powder and solvent for solution for injection Moroctocog alfa.